BDTX FY 2024 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$126M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$79M

Net Income

-$70M

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$62M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$123M

Total Liabilities

$39M

Stockholders' Equity

$83M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$437,000	+100.0%
Operating Income	-$79M	-$86M	+8.9%
Net Income	-$70M	-$82M	+15.5%